[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "FITNESS PRIDE ZFA AC PATCH TAB individual RECOMMENDED PRIDE:0000833 TMT cell type INCLUDING CPTAC RECOMMEND REQUIRED exclamation SILAC PRIDE:0000659 ANY age CS HCD MUST WARRANTY ancestry category CT collision energy PRIDE:0000831 biosample accession number BMC NCI REQUIRES CF NCIT MIAME LI PRIDE:0000834 MHC ... PS MAGE sex SDRF IDF SHOULD BTO INITIATIVE NCIT:C25683 XML VK WARRANTIES source name EFO DJ SN STANDARDS CL PRIDE:0000832 ISA README MAJOR SHALL ALL WILL CID MC SWATH AS PP TO PARTICULAR depletion THE dissociation method HANCESTRO MINOR DDA instrument XL TA SP organism RIGHTS alkylation reagent CN cleavage agent details RAW RFC pooled sample IMPLIED FOR INFORMATION spiked compound SAMEA EXPRESS organism part CLO PMID II SH USE HTML PSI PEPTIDESEQ technical replicate label HF characteristics PROTEOMICS MAY COLUMN OPTIONAL DIA MOD OR PATO:0000461 MONDO biological replicate INFRINGE NCIT:C25714 CV developmental stage MS:1001251 HUPO PRM PTM mass MT URI fraction identifier PO PURPOSE sample data file TIP file your VCF SRM BUT EM DTT BE III NOTE MERCHANTABILITY EW IAA ID NCE LC HEREIN OF MS fractionation method LIMITED IS PMCID JA EBI IMPORTANT disease SAMN proteomics data acquisition method UBERON QY NOT ROW CELL BRENDA NCBI reduction reagent URL THAT COULD FDR PATO ENVO DISCLAIMS NT"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "FITNESS PRIDE ZFA AC PATCH TAB individual RECOMMENDED PRIDE:0000833 TMT cell type INCLUDING CPTAC RECOMMEND REQUIRED SILAC PRIDE:0000659 ANY age CS HCD MUST WARRANTY CT collision energy PRIDE:0000831 biosample accession number BMC NCI REQUIRES CF NCIT MIAME LI PRIDE:0000834 MHC ... PS MAGE SDRF IDF SHOULD BTO INITIATIVE NCIT:C25683 VK WARRANTIES EFO DJ SN STANDARDS CL PRIDE:0000832 ISA README MAJOR SHALL ALL WILL CID MC SWATH AS PP TO PARTICULAR depletion THE dissociation method HANCESTRO MINOR DDA instrument XL TA SP organism RIGHTS alkylation reagent CN cleavage agent details RAW RFC pooled sample IMPLIED FOR INFORMATION spiked compound SAMEA EXPRESS organism part CLO PMID II SH USE HTML PSI PEPTIDESEQ technical replicate label HF PROTEOMICS MAY COLUMN OPTIONAL DIA MOD OR PATO:0000461 MONDO biological replicate INFRINGE NCIT:C25714 CV MS:1001251 HUPO PRM PTM mass MT URI fraction identifier PO PURPOSE data file VCF SRM BUT EM DTT BE III MERCHANTABILITY EW IAA NCE LC HEREIN OF MS fractionation method LIMITED IS PMCID JA EBI disease SAMN proteomics data acquisition method UBERON QY NOT ROW CELL BRENDA NCBI reduction reagent URL THAT COULD FDR PATO ENVO DISCLAIMS NT"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nHealthy Samples: normal vs healthy vs control\n\nFor samples without disease, the terminology matters for standardization:\n\nnormal (PATO:0000461) - Recommended\n\n- S",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "PO organism CL:0000066 DOID EFO PDX MONDO:0005148 cell type synthetic peptide UBERON:0000178 APP NOTE exclamation age organism part CL ID PATO:0001421 MUST CL:0000815 disease UBERON:0002107 MAY UBERON MONDO:0004989 depletion CL:0000624 xenograft CL:0000084 enrichment process PATO:0000461 MONDO NCBI MONDO:0004975 SDRF developmental stage PTM PATO"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nHealthy Samples: normal vs healthy vs control\n\nFor samples without disease, the terminology matters for standardization:\n\nnormal (PATO:0000461) - Recommended\n\n- S",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "PO organism CL:0000066 DOID EFO PDX MONDO:0005148 cell type synthetic peptide UBERON:0000178 APP age organism part CL ID PATO:0001421 MUST CL:0000815 disease UBERON:0002107 MAY UBERON MONDO:0004989 depletion CL:0000624 xenograft CL:0000084 enrichment process PATO:0000461 MONDO NCBI MONDO:0004975 SDRF developmental stage PTM PATO"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "HIPAA treatment MONDO:0005044 individual MONDO:0005148 NCIT:C28076 TNM staging NCIT:C65107 breast cancer subtype pre-existing condition compound CHEBI:27899 NCIT:C15262 HANCESTRO:0005 menopausal status exclamation CHEBI:28748 IV organism part NCIT:C15632 NCIT:C71732 ID treatment status body mass index sampling time point NCIT:C4870 ancestry category NCIT:C65106 IMPORTANT NCI AJCC NCIT:C18206 GDPR NCIT smoking status dose Ann Arbor stage tumor grade HANCESTRO MONDO TNM treatment response Dukes stage SDRF HANCESTRO:0009 PR ER NCIT:C28078 NCIT:C65108 NCIT:C27971 disease stage NCIT:C27966 NCIT:C53554 weight"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "HIPAA treatment MONDO:0005044 individual MONDO:0005148 NCIT:C28076 TNM staging NCIT:C65107 breast cancer subtype pre-existing condition compound CHEBI:27899 NCIT:C15262 HANCESTRO:0005 menopausal status CHEBI:28748 IV organism part NCIT:C15632 NCIT:C71732 ID treatment status body mass index sampling time point NCIT:C4870 ancestry category NCIT:C65106 NCI AJCC NCIT:C18206 GDPR NCIT smoking status dose Ann Arbor stage tumor grade HANCESTRO MONDO TNM treatment response Dukes stage SDRF HANCESTRO:0009 PR ER NCIT:C28078 NCIT:C65108 NCIT:C27971 disease stage NCIT:C27966 NCIT:C53554 weight"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Analyzer Type\n\nColumn: comment[MS2 analyzer type]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {lower}m/z - {upper}m/z (e.g., 400m/z - 1200m/z)\n\nAlternative: Use comment[scan window lower limit] and comment[scan window upper limit] as separate columns.\n\nProtein Modifications\n\nColumn: comment[modification parameters]\n\nFormat: Key=value pairs: NT=ModificationName;AC=Accession;MT=Type;TA=AminoAcid;PP=Position\n\nProperty |Key |Description\n\nName |NT |Modification name (UNIMOD or PSI-MOD)\nAccession |AC |UNIMOD or PSI-MOD accession\n\nCommon modifications:\n\nModification |Value\n\nCarbamidomethyl (fixed) |NT=Carbamidomethyl;AC=UNIMOD:4;MT=Fixed;TA=C\nOxidation (variable) |NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M\n\nCleavage Agents\n\nColumn: comment[cleavage agent details]\n\nREQUIRED.\n\nFormat: NT=EnzymeName;AC=Accession\n\nEnzyme |Value\n\nTrypsin |NT=Trypsin;AC=MS:1001251\nLys-C |NT=Lys-C;AC=MS:1001309\n\nFor top-down/intact proteins, use not applicable. For multiple enzymes, add multiple columns.\n\nMass Tolerances\n\nColumns: comment[precursor mass tolerance], comment[fragment mass tolerance]\n\nForm",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "TA PRIDE scan window upper limit AC cleavage agent details TMT precursor mass tolerance MS:1001309 REQUIRED modification parameters exclamation SILAC MS1 scan range UNIMOD:4 README PSI MS label UNIMOD MS2 analyzer type UNIMOD:35 PP scan window lower limit DIA MOD fragment mass tolerance SDRF MS:1001251 MT NT"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Analyzer Type\n\nColumn: comment[MS2 analyzer type]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {lower}m/z - {upper}m/z (e.g., 400m/z - 1200m/z)\n\nAlternative: Use comment[scan window lower limit] and comment[scan window upper limit] as separate columns.\n\nProtein Modifications\n\nColumn: comment[modification parameters]\n\nFormat: Key=value pairs: NT=ModificationName;AC=Accession;MT=Type;TA=AminoAcid;PP=Position\n\nProperty |Key |Description\n\nName |NT |Modification name (UNIMOD or PSI-MOD)\nAccession |AC |UNIMOD or PSI-MOD accession\n\nCommon modifications:\n\nModification |Value\n\nCarbamidomethyl (fixed) |NT=Carbamidomethyl;AC=UNIMOD:4;MT=Fixed;TA=C\nOxidation (variable) |NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M\n\nCleavage Agents\n\nColumn: comment[cleavage agent details]\n\nREQUIRED.\n\nFormat: NT=EnzymeName;AC=Accession\n\nEnzyme |Value\n\nTrypsin |NT=Trypsin;AC=MS:1001251\nLys-C |NT=Lys-C;AC=MS:1001309\n\nFor top-down/intact proteins, use not applicable. For multiple enzymes, add multiple columns.\n\nMass Tolerances\n\nColumns: comment[precursor mass tolerance], comment[fragment mass tolerance]\n\nForm",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "TA PRIDE scan window upper limit AC cleavage agent details TMT precursor mass tolerance MS:1001309 REQUIRED modification parameters SILAC MS1 scan range UNIMOD:4 PSI MS label UNIMOD MS2 analyzer type UNIMOD:35 PP scan window lower limit DIA MOD fragment mass tolerance SDRF MS:1001251 MT NT"
  }
]